siRNA疗法:见解,挑战,补救措施和未来的前景
Saba Khan1, Urushi Rehman1, Neha Parveen1
1Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
Expert opinion on drug delivery
|August 29, 2023
概括
RNA干扰 (siRNA) 疗法为疾病治疗提供基因沉默. 克服传递障碍是解锁siRNA的关键.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- RNA干扰 (siRNA) 疗法代表了一种通过沉默特定基因来治疗疾病的新方法.
- 尽管有很大的潜力,但siRNA疗法的临床应用受到各种病理生理障碍的阻碍,这些障碍影响了目标传递和基因沉默的有效性.
研究的目的:
- 审查siRNA疗法的当前前景观,重点关注体内挑战和交付策略.
- 突出正在进行的临床试验和siRNA模式的监管考虑.
主要方法:
- 审查关于siRNA传递系统和治疗应用的现有文献.
- 对体内障碍的分析和为siRNA可访问性提出的解决方案.
- 对基于siRNA的治疗方法的临床试验数据和监管途径的检查.
主要成果:
- siRNA疗法可以使用纳米颗粒 (聚合物或脂质) 和合物进行修改,以提高目标部位的可访问性.
- 先进的药物输送策略对于克服体内障碍和实现有效的基因沉默至关重要.
- 目前正在进行的研究表明,克服分娩挑战是有前途的,这可能导致革命性的治疗结果.
结论:
- 有效地将siRNA输送到向组织仍然是治疗成功的关键挑战.
- 配方和输送技术的进步正在为siRNA疗法的更广泛的临床采用铺平道路.
- 该领域正在向新的批准和对基因沉默疗法的重大临床影响取得进展.
相关概念视频
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
02:30Small interfering RNAs (siRNA)
3.6K
3.6K
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
01:23RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
02:57piRNA - Piwi-interacting RNAs
6.9K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
01:29Microorganisms in Medicine and Therapeutics
53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53